FogPharma Alternatives & Competitors
12 companies similar to FogPharma — Until everything is druggable.
AiCuris Anti-infective Cures AG
Delivering Novel Anti-Viral Therapies to Patients with Weakened Immune Systems
Wuppertal, Germany
Azome Therapeutics
Developing selective NLRP3 inflammasome inhibitors for severe inflammatory diseases
Harness Therapeutics
Unlocking New Targets to Transform the Treatment of Neurodegenerative Diseases
Cambridge, United Kingdom
TORL BioTherapeutics LLC
Advancing novel antibody-based therapies to transform the lives of cancer patients.
Culver City, United State...
Track all FogPharma competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Bexion Pharmaceuticals
Bexion Pharmaceuticals is a mid-stage clinical company developing life-changing treatments...
Covington, United States
T-knife Therapeutics
T-knife uses a mouse platform to create human TCRs for cancer treatment without modificati...
San Francisco, United Sta...
Cybrexa Therapeutics
Changing the paradigm for cancer treatment through the development of antigen-independent...
New Haven, United States
RHEACELL GmbH & Co. KG
Innovative Stem Cell Therapies Experts from Heidelberg, Germany
Heidelberg, Germany
Affini-T Therapeutics
Right Targets. Right Cells. Right Place. Unlocking the power of T cells against oncogenic...
Watertown, United States
ROME Therapeutics
Harnessing the power of the repeatome to develop a new class of therapies for cancer and a...
Boston, United States
Granza Bio
Reprogramming Immunity for Target-Specific Medicines
3T Biosciences
3T is an immunotherapy company developing next-generation, transformative therapies for br...
South San Francisco, Unit...
About FogPharma
Until everything is druggable.
development of ultra-tunable peptide therapeutics, research and development of novel cancer treatments, platform for drug discovery and innovation
patients with severe diseases, healthcare providers treating cancer and desmoid tumors, research institutions and collaborators in oncology
Drug Discovery, Helicon Peptides, Precision Medicine, Cell-penetrating Peptides, Oncology, Cancer Treatment, Novel Drug Development, Therapeutics, Monoclonal Antibodies, Small Molecules, Undruggable Targets, Entrepreneurial Innovation, Cancer Biology
B2B, B2D, Platform
Licensing, Product Sales
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches FogPharma and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at FogPharma on 11 Mar 2026. The 12 companies listed here were last checked between 28 Jan 2026 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
